Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
niclosamide (FW-1022) / First Wave Bio
RESERVOIR, NCT04858425: Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection	Terminated	2	166	US, RoW	Niclosamide, Placebo	Entero Therapeutics	Covid19	06/22	09/23